| Aug 21 |
Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance
|
| Aug 15 |
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
|
| Aug 15 |
Tempest jumps as FDA aligns with trial design for cancer drug
|
| Aug 15 |
Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
|
| Aug 9 |
Tempest Therapeutics GAAP EPS of -$0.42 misses by $0.02
|
| Aug 8 |
Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update
|
| Jul 19 |
Tempest Therapeutics files for mixed shelf offering of up to $300M
|
| Jul 5 |
$55M Bet On Archer Aviation? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
|
| Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
| Jun 20 |
Tempest falls after new trial data for liver cancer therapy
|
